Evidence map›Paper›PMID 33496186›Full record

ArticleJournal of the American Heart Association2021

Endovascular Thrombectomy Versus Bridging Thrombolysis: Real-World Efficacy and Safety Analysis Based on a Nationwide Registry Study.

Chang Geng, Sheng-De Li, Ding-Ding Zhang, Lin Ma, Guo-Wei Liu, Li-Qun Jiao, Jian-Min Liu, Wen-Huo Chen, Wu-Sheng Zhu, Chang-Ming Wen and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chang GengDepartment of Neurology Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Sheng-De LiDepartment of Neurology Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Ding-Ding ZhangMedical Research Center Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Lin MaDepartment of Interventional Radiology Shanghai Tongji HospitalTongji University School of Medicine Shanghai China.
Guo-Wei LiuDepartment of Critical Care Medicine Xinxiang Central Hospital Xinxiang City Henan Province China.
Li-Qun JiaoDepartment of Neurosurgery Xuanwu HospitalCapital Medical University Beijing China.
Jian-Min LiuDepartment of Neurosurgery Changhai HospitalSecond Military Medical University Shanghai China.
Wen-Huo ChenDepartment of Neurology Zhangzhou Hospital of Fujian Medical University Zhangzhou City Fujian Province China.
Wu-Sheng ZhuDepartment of Neurology Jinling HospitalMedical School of Nanjing University Nanjing Jiangsu Province China.
Chang-Ming WenDepartment of Neurology Nanyang Central Hospital Nanyang City Henan Province China.
Bin PengDepartment of Neurology Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background It was uncertain if direct endovascular thrombectomy (ET) was superior to bridging thrombolysis (BT) for patients with acute ischemic stroke caused by large-vessel occlusions. We aimed to examine real-world clinical outcomes of ET using nationwide registry data in China and to compare the efficacy and safety between BT and direct ET. Methods and Results Patients treated with ET from a nationwide registry study in China were included. Rapid neurological improvement, intracranial hemorrhage, and in-hospital mortality were compared between the 2 groups using multivariate logistic models and propensity-score matching analyses. A total of 7674 patients from 592 stroke centers were included. The median onset-to-puncture time, onset-to-door time, and door to puncture time were 290, 170, and 99 minutes, respectively. A total of 2069 (27.0%) patients received BT treatment. Patients in the BT group had a significantly shorter onset-to-puncture time (235 versus 323 minutes;

Indexed as

RegistriesAgedBrain IschemiaChinaEndovascular ProceduresFemaleFibrinolytic AgentsFollow-Up StudiesHospital MortalityHumansMaleMiddle AgedPrognosisPropensity ScoreRetrospective StudiesThrombectomyFibrinolytic Agentsendovascular thrombectomyischemic strokeoutcomethrombolysis

Identifiers

PMID33496186
PMCPMC7955444

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.